Dkk-3 is elevated in CSF and plasma of Alzheimer's disease patients
about
Cerebrospinal fluid biomarkers of Alzheimer’s diseaseDysfunction of Wnt signaling and synaptic disassembly in neurodegenerative diseases.Neurodevelopment in schizophrenia: the role of the wnt pathways.Blood-based biomarkers of Alzheimer's disease: challenging but feasibleDifferential expression of Wnts after spinal cord contusion injury in adult rats.Synaptic Wnt signaling-a contributor to major psychiatric disorders?Signaling pathway cross talk in Alzheimer's diseaseProteomic analysis of cerebrospinal fluid in California sea lions (Zalophus californianus) with domoic acid toxicosis identifies proteins associated with neurodegeneration.Dkk3 prevents familial dilated cardiomyopathy development through Wnt pathway.Dickkopf-3 alters the morphological response to retinoic acid during neuronal differentiation of human embryonal carcinoma cells.Elevated levels of Dickkopf-related protein 3 in seminal plasma of prostate cancer patients.Dickkopf-related protein 3 promotes pathogenic stromal remodeling in benign prostatic hyperplasia and prostate cancer.Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer's disease.Multiplexing Biomarker Methods, Proteomics and Considerations for Alzheimer's Disease.Dickkopf-related protein 3 is a potential Aβ-associated protein in Alzheimer's Disease.Deficient Wnt Signaling and Synaptic Vulnerability in Alzheimer’s Disease: Emerging Roles for the LRP6 Receptor
P2860
Q22252572-0D271554-6B24-48F7-B493-88C00F2283FEQ29347521-DD974699-7F09-4955-8DC6-E14BE00997A5Q30442237-927EB572-76F5-4C74-9C87-F4A117703E24Q33824444-395C1FB0-3079-4D88-8C99-0C83E317236AQ34071712-0A9E61F2-CD6C-4AA2-9593-C7C2BC23389AQ35234350-DFA55348-F0B9-45DB-B6BE-B24BEDAC2CA0Q38200151-49741B0F-4CD8-4783-8646-F99057B3558BQ38403840-99ED15EB-E6ED-4BD3-A59D-9178AF63D92CQ38814061-50DB4566-9EF8-4B46-BC13-3C4AE7A6FC6AQ38987095-2D8A6418-511B-426A-9ECE-71C43A4CAB23Q39867828-65AC2D9B-A70C-4070-B58A-4C6DC8C16269Q42073864-C673D17A-D843-4E27-BB78-D1533E66FB79Q42580206-9500EF21-F710-40C4-9383-528E665E916BQ47407570-B7766226-3018-42DE-933E-1022C360CD19Q48105192-3B5A8CBE-0C3E-4BE0-A9F8-576988D498B1Q58698087-C549B4F2-F3CE-47C1-8D18-C95008606D62
P2860
Dkk-3 is elevated in CSF and plasma of Alzheimer's disease patients
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Dkk-3 is elevated in CSF and plasma of Alzheimer's disease patients
@ast
Dkk-3 is elevated in CSF and plasma of Alzheimer's disease patients
@en
type
label
Dkk-3 is elevated in CSF and plasma of Alzheimer's disease patients
@ast
Dkk-3 is elevated in CSF and plasma of Alzheimer's disease patients
@en
prefLabel
Dkk-3 is elevated in CSF and plasma of Alzheimer's disease patients
@ast
Dkk-3 is elevated in CSF and plasma of Alzheimer's disease patients
@en
P2093
P2860
P1476
Dkk-3 is elevated in CSF and plasma of Alzheimer's disease patients
@en
P2093
Andreas Kiefer
Christian Humpel
Christoph Zenzmaier
Josef Marksteiner
Peter Berger
P2860
P304
P356
10.1111/J.1471-4159.2009.06158.X
P407
P577
2009-05-11T00:00:00Z